Nephrodite

Nephrodite is pioneering the first implantable, continuous hemodialysis platform designed to restore independence and quality of life for people with end-stage kidney disease. Our investigational Holly™ platform is designed to provide a true kidney replacement therapy alternative through proprietary membrane technology and edge computing-enabled hemofiltration. Founded by physicians and powered by world-class biomedical engineers, Nephrodite is advancing a new model of kidney care built around mobility, dignity, and independence. We're building a future where kidney care is no longer defined by life in a dialysis chair.